[go: up one dir, main page]

ATE270890T1 - Optische papillarzirkulation verbesserende mittel - Google Patents

Optische papillarzirkulation verbesserende mittel

Info

Publication number
ATE270890T1
ATE270890T1 AT99900647T AT99900647T ATE270890T1 AT E270890 T1 ATE270890 T1 AT E270890T1 AT 99900647 T AT99900647 T AT 99900647T AT 99900647 T AT99900647 T AT 99900647T AT E270890 T1 ATE270890 T1 AT E270890T1
Authority
AT
Austria
Prior art keywords
optic nerve
nerve head
papillary
optical
circulation
Prior art date
Application number
AT99900647T
Other languages
English (en)
Inventor
Hideaki Hara
Masamitsu Shimazawa
Yasushi Iwakura
Tetsuya Sugiyama
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE270890T1 publication Critical patent/ATE270890T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT99900647T 1998-01-29 1999-01-21 Optische papillarzirkulation verbesserende mittel ATE270890T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1683198 1998-01-29
JP25237598 1998-09-07
PCT/JP1999/000202 WO1999038515A1 (fr) 1998-01-29 1999-01-21 Agents ameliorant la circulation optique papillaire

Publications (1)

Publication Number Publication Date
ATE270890T1 true ATE270890T1 (de) 2004-07-15

Family

ID=26353257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99900647T ATE270890T1 (de) 1998-01-29 1999-01-21 Optische papillarzirkulation verbesserende mittel

Country Status (11)

Country Link
US (1) US6387910B1 (de)
EP (1) EP1051973B1 (de)
JP (1) JP4456269B2 (de)
KR (1) KR100585299B1 (de)
CN (1) CN1149086C (de)
AT (1) ATE270890T1 (de)
DE (1) DE69918671T2 (de)
ES (1) ES2224597T3 (de)
PT (1) PT1051973E (de)
TW (1) TW461815B (de)
WO (1) WO1999038515A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011148888A1 (ja) * 2010-05-27 2011-12-01 あすか製薬株式会社 複素環化合物及びｈ１受容体拮抗剤
CN109580836A (zh) * 2018-12-31 2019-04-05 辰欣药业股份有限公司 一种盐酸洛美利嗪原料及制剂有关物质的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60222472A (ja) * 1984-03-30 1985-11-07 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
WO1990006123A1 (en) 1988-12-05 1990-06-14 Houston Biotechnology Incorporated Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
FR2669132A1 (fr) * 1990-11-09 1992-05-15 Guerin James Dispositif de memorisation d'informations connectable a un ordinateur.
AU4246793A (en) * 1992-05-13 1993-12-13 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents

Also Published As

Publication number Publication date
EP1051973A4 (de) 2002-02-06
KR20010024889A (ko) 2001-03-26
US6387910B1 (en) 2002-05-14
WO1999038515A1 (fr) 1999-08-05
CN1149086C (zh) 2004-05-12
ES2224597T3 (es) 2005-03-01
PT1051973E (pt) 2004-11-30
CN1295475A (zh) 2001-05-16
EP1051973B1 (de) 2004-07-14
TW461815B (en) 2001-11-01
EP1051973A1 (de) 2000-11-15
KR100585299B1 (ko) 2006-06-01
DE69918671T2 (de) 2005-07-28
DE69918671D1 (de) 2004-08-19
JP4456269B2 (ja) 2010-04-28

Similar Documents

Publication Publication Date Title
DE69630325D1 (de) Nervenschutzende für Auge von Säugern unter Anwendung von Kaliumkanalblockern
DK1572230T3 (da) Placenta alkalisk phosphatase til at kontrollere diabetes
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
FI942499A0 (fi) Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
ATE281464T1 (de) Adenosinderivate und deren verwendung
ES2109752T3 (es) Medicamento para tratamiento terapeutico y profilactico de enfermedades causadas por hiperplasia de las celulas de los musculos lisos.
ATE270890T1 (de) Optische papillarzirkulation verbesserende mittel
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
RU2004129767A (ru) Хинолиновые производные
WO2003011299A3 (en) Treatment of ocular hypertension and glaucoma
IT1313583B1 (it) Derivati 2-amminotetralinici per la terapia del glaucoma.
ATE215824T1 (de) Mittel zur verminderung des augeninnendrucks
DK0985414T3 (da) Lægemiddel til behandling af glaukome og iskæmisk retinopati
DE69829227D1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
NO20013480D0 (no) Legemiddel for törr hud
RU99100578A (ru) Способ лечения глазных болезней
Mittag et al. Alpha-adrenergic agonists and aqueous humor dynamics
BR0110852A (pt) Composições que contêm um derivado dissulfeto de benzamida para tratamento de doenças alérgicas
Sugrue Preclinical pharmacology of topical ocular hypotensive carbonic anhydrase inhibitors
Bito Ocular hypotensive effects of prostaglandins (PGs) and their analogs
ATE160937T1 (de) Die verwendung von 2-phenylmethylene-1-3'-(amino)-2-(hydroxy)-prop xy-imino-cyclohexane-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1051973

Country of ref document: EP

REN Ceased due to non-payment of the annual fee